<DOC>
	<DOCNO>NCT01211665</DOCNO>
	<brief_summary>The objective study explore effect administer high-dose corticosteroid participant develop progressive multifocal leukoencephalopathy ( PML ) natalizumab measure time-course change functional status base Karnofsky Performance Status Index 6 month follow completion plasma exchange ( PLEX ; equivalent ) , survival 6 month follow completion PLEX ( equivalent ) , incidence severity adverse event ( AEs ) serious adverse event ( SAEs ) ; characterize evolution immune reconstitution inflammatory syndrome ( IRIS ) measure time course change Global Clinical Impression Improvement ( GCI-I ) , Symbol Digit Modalities Test ( SDMT ) , brain magnetic resonance imaging ( MRI ) , magnetoencephalography ( MEG ) , chemokines , cytokine , C-reactive protein ( CRP ) , John Cunningham virus ( JCV ) load cell count cerebrospinal fluid ( CSF ) ; characterize time course elimination serum natalizumab concentration study population follow last PLEX ( equivalent ) procedure .</brief_summary>
	<brief_title>Corticosteroids Immune Reconstitution Inflammatory Syndrome ( IRIS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukoencephalopathies</mesh_term>
	<mesh_term>Leukoencephalopathy , Progressive Multifocal</mesh_term>
	<mesh_term>Immune Reconstitution Inflammatory Syndrome</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Key Must receive natalizumab multiple sclerosis ( MS ) prior diagnosis suspicion Progressive multifocal leukoencephalopathy ( PML ) . Subject must willing undergo complete plasma exchange ( PLEX ) prior initiate study treatment . Key History severe allergic anaphylactic reaction know hypersensitivity drug include hypersensitivity corticosteroid . NOTE : Other protocol define inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>IVMP</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>IRIS</keyword>
	<keyword>Progressive Multifocal Leukoencephalopathy</keyword>
	<keyword>Immune reconstitution inflammatory syndrome</keyword>
	<keyword>PML</keyword>
</DOC>